Signals of Th2 immune response from COVID-19 patients requiring intensive care

被引：101

作者：

Roncati, Luca ^{[1
]}

Nasillo, Vincenzo ^{[1
]}

Lusenti, Beatrice ^{[1
]}

Riva, Giovanni ^{[1
]}

机构：

[1] Univ Hosp Modena, Hemolymphopathol Team, Modena, Italy

来源：

ANNALS OF HEMATOLOGY | 2020年 / 99卷 / 06期

关键词：

D O I：

10.1007/s00277-020-04066-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1419 / 1420

页数：2

共 5 条

[1] Eosinophils and their interactions with respiratory virus pathogens [J].

Rosenberg, Helene F. ;

Dyer, Kimberly D. ;

Domachowske, Joseph B. .

IMMUNOLOGIC RESEARCH, 2009, 43 (1-3) :128-137

[2] Aging Enhances the Basal Production of IL-6 and CCL2 in Vascular Smooth Muscle Cells [J].

Song, Yang ;

Shen, Hua ;

Schenten, Dominik ;

Shan, Peiying ;

Lee, Patty J. ;

Goldstein, Daniel R. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (01) :103-U267

[3] Type 1 type 2 immunity in infectious diseases [J].

Spellberg, B ;

Edwards, JE .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :76-102

[4]

Wei XS, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3546120, DOI 10.2139/SSRN.3546120]

[5] Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality [J].

Zhang, Chi ;

Wu, Zhao ;

Li, Jia-Wen ;

Zhao, Hong ;

Wang, Gui-Qiang .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)

← 1 →